These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 31709647)

  • 1. Seroprevalence and factors associated with IgG anti-DENV positivity in blood donors in Burkina Faso during the 2016 dengue outbreak and implications for blood supply.
    Sawadogo S; Baguiya A; Yougbare F; Bicaba BW; Nebie K; Millogo T; Kamba I; Kaba L; Sangare L; Kafando E; Deneys V
    Transfus Med; 2020 Feb; 30(1):37-45. PubMed ID: 31709647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dengue virus serological markers among potential blood donors: an evidence of asymptomatic dengue virus transmission in Cameroon.
    Tchuandom SB; Lissom A; Ateba GHM; Tchouangueu TF; Tchakounte C; Ayuk AR; Atabonkeng EP; Ngong AI; Nchinda G; Kuiate JR
    Pan Afr Med J; 2020; 36():185. PubMed ID: 32952829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dengue seroprevalence among asymptomatic blood donors during an epidemic outbreak in Central-West Brazil.
    Slavov SN; Cilião-Alves DC; Gonzaga FAC; Moura DR; de Moura ACAM; de Noronha LAG; Cassemiro ÉM; Pimentel BMS; Costa FJQ; da Silva GA; Ramos DDAR; de Araújo WN; Kashima S; Haddad R
    PLoS One; 2019; 14(3):e0213793. PubMed ID: 30908528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dengue RNA detection and seroprevalence in blood donors during an outbreak in the São Paulo State, Brazil, 2016.
    Slavov SN; Santos EV; Hespanhol MR; Rodrigues ES; Haddad R; Ubiali EMA; Covas DT; Kashima S
    J Med Virol; 2021 Jun; 93(6):3344-3349. PubMed ID: 33090520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroprevalence of six different viruses among pregnant women and blood donors in rural and urban Burkina Faso: A comparative analysis.
    Collenberg E; Ouedraogo T; Ganamé J; Fickenscher H; Kynast-Wolf G; Becher H; Kouyaté B; Kräusslich HG; Sangaré L; Tebit DM
    J Med Virol; 2006 May; 78(5):683-92. PubMed ID: 16555290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dengue virus antibodies in blood donors from an endemic area.
    Rodríguez Rodríguez D; Garza Rodríguez M; Chavarria AM; Ramos-Jiménez J; Rivera MA; Taméz RC; Farfan-Ale J; Rivas-Estilla AM
    Transfus Med; 2009 Jun; 19(3):125-31. PubMed ID: 19566669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevalence of dengue virus serotypes in asymptomatic blood donors reveals the emergence of serotype 4 in Saudi Arabia.
    Ashshi AM
    Virol J; 2017 Jun; 14(1):107. PubMed ID: 28599678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and epidemiologic characteristics associated with dengue during and outside the 2016 outbreak identified in health facility-based surveillance in Ouagadougou, Burkina Faso.
    Lim JK; Seydou Y; Carabali M; Barro A; Dahourou DL; Lee KS; Nikiema T; Namkung S; Lee JS; Shin MY; Bonnet E; Kagone T; Kaba L; Edwards T; Somé PA; Yang JS; Alexander N; Yoon IK; Ridde V
    PLoS Negl Trop Dis; 2019 Dec; 13(12):e0007882. PubMed ID: 31809504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dengue virus transmission risk in blood donation: Evidence from Thailand.
    Limothai U; Tachaboon S; Dinhuzen J; Singh J; Leewongworasingh A; Watanaboonyongcharoen P; Fernandez S; Hunsawong T; Farmer AR; Tantawichien T; Thisyakorn U; Srisawat N
    J Med Virol; 2024 Jun; 96(6):e29689. PubMed ID: 38818789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Investigation of dengue virus and yellow fever virus seropositivities in blood donors from Central/Northern Anatolia, Turkey].
    Ergünay K; Saygan MB; Aydoğan S; Litzba N; Niedrig M; Pınar A; Us D
    Mikrobiyol Bul; 2010 Jul; 44(3):415-24. PubMed ID: 21063991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low frequency of asymptomatic dengue virus-infected donors in blood donor centers during the largest dengue outbreak in Taiwan.
    Tsai JJ; Lin PC; Tsai CY; Wang YH; Liu LT
    PLoS One; 2018; 13(10):e0205248. PubMed ID: 30296301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High seroprevalence of anti-DENV IgM in blood donors in an early outbreak in the Federal District of Brazil, 2019.
    Cilião-Alves DC; Barcelos SM; Bezerra ALO; Almeida IS; Silveira JVM; Alencar JP; Pimentel BMS; Araújo WN; Haddad R
    J Med Microbiol; 2021 Oct; 70(10):. PubMed ID: 34668855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An evaluation of asymptomatic Dengue infections among blood donors during the 2014 Dengue outbreak in Guangzhou, China.
    Liao Q; Shan Z; Wang M; Huang J; Xu R; Huang K; Tang X; Zhang W; Nelson K; Li C; Fu Y; Rong X
    J Med Virol; 2017 Nov; 89(11):2037-2040. PubMed ID: 28639699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First dengue virus seroprevalence study on Madeira Island after the 2012 outbreak indicates unreported dengue circulation.
    Auerswald H; de Jesus A; Seixas G; Nazareth T; In S; Mao S; Duong V; Silva AC; Paul R; Dussart P; Sousa CA
    Parasit Vectors; 2019 Mar; 12(1):103. PubMed ID: 30867031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transfusion transmitted virus and dengue virus among healthy blood donors: A prevalence report from Jordan.
    Swedan S; Al-Saleh D
    Biomol Biomed; 2023 May; 23(3):450-456. PubMed ID: 36475356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probable and possible transfusion-transmitted dengue associated with NS1 antigen-negative but RNA confirmed-positive red blood cells.
    Matos D; Tomashek KM; Perez-Padilla J; Muñoz-Jordán J; Hunsperger E; Horiuchi K; Noyd D; Winton C; Foster G; Lanteri M; Linnen JM; Stramer SL
    Transfusion; 2016 Jan; 56(1):215-22. PubMed ID: 26469514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of transfusion-associated dengue: screening of blood donors from Pune, western India.
    Kulkarni R; Tiraki D; Wani D; Mishra AC; Arankalle VA
    Transfusion; 2019 Feb; 59(2):458-462. PubMed ID: 30727040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duration of Dengue Viremia in Blood Donors and Relationships Between Donor Viremia, Infection Incidence and Clinical Case Reports During a Large Epidemic.
    Busch MP; Sabino EC; Brambilla D; Lopes ME; Capuani L; Chowdhury D; McClure C; Linnen JM; Prince H; Simmons G; Lee TH; Kleinman S; Custer B;
    J Infect Dis; 2016 Jul; 214(1):49-54. PubMed ID: 27302934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiological survey and screening strategy for dengue virus in blood donors from Yunnan Province.
    Li L; Li Y; Lu S; Dong J; Xu H; Zhang Q; Weng R; Yin Y; He R; Fang P; Shi H; Yu Y; Wu J; Liu Z; Hess JR
    BMC Infect Dis; 2021 Jan; 21(1):104. PubMed ID: 33482756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of anti-dengue immunoglobulin G antibodies among American Red Cross blood donors in Puerto Rico, 2006.
    Mohammed H; Tomashek KM; Stramer SL; Hunsperger E
    Transfusion; 2012 Aug; 52(8):1652-6. PubMed ID: 22224623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.